1. Home
  2. CASH vs HROW Comparison

CASH vs HROW Comparison

Compare CASH & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$83.68

Market Cap

1.8B

Sector

Finance

ML Signal

HOLD

HROW

Harrow Inc.

HOLD

Current Price

$40.95

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CASH
HROW
Founded
1954
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
1.7B
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
CASH
HROW
Price
$83.68
$40.95
Analyst Decision
Buy
Strong Buy
Analyst Count
2
8
Target Price
$107.50
$69.86
AVG Volume (30 Days)
167.3K
539.0K
Earning Date
04-22-2026
05-11-2026
Dividend Yield
0.23%
N/A
EPS Growth
N/A
71.43
EPS
6.29
N/A
Revenue
$839,894,000.00
N/A
Revenue This Year
$7.56
$31.62
Revenue Next Year
$6.02
$50.77
P/E Ratio
$13.35
N/A
Revenue Growth
11.29
N/A
52 Week Low
$65.93
$28.54
52 Week High
$101.26
$54.98

Technical Indicators

Market Signals
Indicator
CASH
HROW
Relative Strength Index (RSI) 36.97 53.97
Support Level $80.30 $40.65
Resistance Level $85.41 $42.11
Average True Range (ATR) 1.59 1.96
MACD -0.54 0.26
Stochastic Oscillator 12.41 68.13

Price Performance

Historical Comparison
CASH
HROW

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: